- Conditions
- Critical Limb Ischemia
- Interventions
- Ixmyelocel-T, Placebo
- Biological · Other
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 35 Years to 90 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 86
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 63 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Ischemic Dilated Cardiomyopathy (IDCM)
- Interventions
- ixmyelocel-T, Placebo
- Biological · Other
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 30 Years to 86 Years
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 34
- States / cities
- Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 27 more
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Ixmyelocel-T, Standard of Care
- Biological · Other
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years to 86 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 5
- States / cities
- Atlanta, Georgia • Cleveland, Ohio • Dallas, Texas + 2 more
- Conditions
- Articular Cartilage
- Interventions
- Carticel (autologous cultured chondrocyte) implantation
- Biological
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 126 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2005
- U.S. locations
- 25
- States / cities
- Los Angeles, California • San Diego, California • Santa Monica, California + 22 more
- Conditions
- Chondral Defect, Articular Cartilage Defect
- Interventions
- autologous cultured chondrocytes on porcine collagen membrane, Bone Marrow Stimulation
- Biological · Procedure
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 17 Years to 65 Years
- Enrollment
- 309 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 7
- States / cities
- Sacramento, California • Washington D.C., District of Columbia • Wichita, Kansas + 4 more
- Conditions
- Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
- Interventions
- MACI, microfracture
- Biological · Procedure
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2030
- U.S. locations
- 14
- States / cities
- Palo Alto, California • Sacramento, California • New Orleans, Louisiana + 9 more
- Conditions
- Peripheral Arterial Disease
- Interventions
- Ixmyelocel-T, Placebo
- Biological
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • San Francisco, California + 16 more
- Conditions
- Osteonecrosis
- Interventions
- Ixmyelocel-T, Standard of Care Only
- Biological · Other
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 3
- States / cities
- Baltimore, Maryland • Minneapolis, Minnesota • Brooklyn, New York
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Ixmyelocel-T, Vehicle Control
- Biological · Other
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years to 86 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 3
- States / cities
- Minneapolis, Minnesota • Cleveland, Ohio • Salt Lake City, Utah
- Conditions
- Fracture, Ununited, Pseudarthrosis
- Interventions
- Fracture surgery, Cultured Bone Marrow Tissue
- Procedure · Drug
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 4
- States / cities
- Des Plaines, Illinois • Ann Arbor, Michigan • Royal Oak, Michigan + 1 more
- Conditions
- Articular Cartilage, Cartilage Diseases
- Interventions
- Carticel (autologous cultured chondrocyte) implantation
- Biological
- Lead sponsor
- Vericel Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 2,233 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1995 – 2009
- U.S. locations
- 1
- States / cities
- Cambridge, Massachusetts
- Conditions
- Alveolar Bone Loss
- Interventions
- Tissue Repair Cells (TRC), Control
- Biological · Device
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 20 Years to 70 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan